MYC and neoplasm: To investigate the impact of MYC gene downregulation on tumor cell immunogenicity, primary HNB cell lines treated with 0.25μM I-BET726/JQ1, as well as untreated control tumor cells were irradiated and co-cultured with autologous PBMCs.